Alan Whone

North Bristol NHS Trust

Papers

1

Total Citations

16

H-Index

1

About

Alan Whone is a leading clinical researcher in movement disorders, with a primary focus on Parkinson’s disease and advanced neuromodulation therapies. His major contributions center on refining deep brain stimulation (DBS) techniques to improve patient outcomes and procedural safety. In his landmark 2020 study, Whone and colleagues demonstrated the clinical efficacy of “asleep” DBS for Parkinson’s disease, using robot-assisted delivery and anatomic targeting of the subthalamic nucleus without traditional microelectrode recordings or intraoperative test stimulation. This work, based on a series of 152 patients, has been cited 16 times and represents a significant step toward more streamlined, less invasive neurosurgical interventions. Whone’s research has helped validate image-guided, frameless approaches that reduce operative time and patient discomfort while maintaining therapeutic benefit. His work is highly regarded for bridging engineering precision with clinical neurology, offering practical advances that directly impact surgical practice. For students and researchers, Whone exemplifies how methodical clinical studies can translate into safer, more accessible treatments for neurodegenerative disease.

Research Focus

Key Achievements

1
H-Index
1
Papers
16
Total Citations
16
Avg Citations/Paper
🏆 Most Cited Paper
Clinical Outcome of “Asleep” Deep Brain Stimulation for Parkinson Disease Using Robot-Assisted Delivery and Anatomic Targeting of the Subthalamic Nucleus: A Series of 152 Patients
16 citations · 2020
📈 Most Prolific Year: 2020 (1 Papers)
🤝 Key Collaborators: 9
🏛 Institutions: North Bristol NHS Trust

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago